The one-shot coronavirus vaccine from Johnson & Johnson is much less effective against the Delta variant than it is against the original version of COVID-19, according to a new study posted online Tuesday.
The study, which examined blood samples in a laboratory…
Study suggests Johnson & Johnson vaccine less effective against Delta variant – New York Post
Share this article
More News
Analysts reset Broadcom stock price target
May 21, 2026
Lumentum Stock Analysis: Buy or Sell?
May 21, 2026